StockNews.com Downgrades Ultralife (NASDAQ:ULBI) to Buy

StockNews.com lowered shares of Ultralife (NASDAQ:ULBI) from a strong-buy rating to a buy rating in a research note published on Thursday.

Separately, Benchmark increased their target price on Ultralife from $13.00 to $14.00 and gave the stock a buy rating in a research report on Thursday, June 27th.

Ultralife Stock Up 0.9 %

Ultralife stock opened at $9.61 on Thursday. The stock has a market cap of $159.72 million, a PE ratio of 15.02 and a beta of 0.97. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.06 and a current ratio of 4.07. Ultralife has a one year low of $6.36 and a one year high of $13.39. The stock has a fifty day moving average of $9.99 and a 200 day moving average of $10.37.

Ultralife (NASDAQ:ULBI) last issued its quarterly earnings results on Thursday, July 25th. The technology company reported $0.22 EPS for the quarter, topping analysts’ consensus estimates of $0.14 by $0.08. The business had revenue of $42.98 million during the quarter. Ultralife had a return on equity of 9.32% and a net margin of 5.96%.

Institutional Investors Weigh In On Ultralife

Several institutional investors have recently modified their holdings of the stock. Visionary Wealth Advisors raised its holdings in shares of Ultralife by 0.9% in the fourth quarter. Visionary Wealth Advisors now owns 1,082,246 shares of the technology company’s stock worth $7,381,000 after buying an additional 9,997 shares during the period. Janney Montgomery Scott LLC raised its holdings in shares of Ultralife by 10.0% in the first quarter. Janney Montgomery Scott LLC now owns 439,100 shares of the technology company’s stock worth $3,868,000 after buying an additional 40,000 shares during the period. Empowered Funds LLC raised its holdings in shares of Ultralife by 7.8% in the first quarter. Empowered Funds LLC now owns 31,396 shares of the technology company’s stock worth $277,000 after buying an additional 2,275 shares during the period. Vanguard Group Inc. raised its holdings in shares of Ultralife by 1.3% in the first quarter. Vanguard Group Inc. now owns 515,840 shares of the technology company’s stock worth $4,545,000 after buying an additional 6,640 shares during the period. Finally, Hillsdale Investment Management Inc. purchased a new stake in shares of Ultralife in the first quarter worth approximately $166,000. 30.68% of the stock is owned by institutional investors.

About Ultralife

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.